Scholarlink

Objectives <p>MRI detects abnormal lung perfusion in patients with cystic fibrosis (CF). However, little is known about the contribution of bronchial arteries to lung perfusion in CF. We hypothesized that delayed perfusion can be detected by dynamic contrast-enhanced (DCE-)MRI and that&#xa0;bronchial artery dilatation (BAD) is associated with changes in lung perfusion.</p> Materials and methods <p>Morpho-functional MRI was prospectively acquired in 75 patients with CF (18.7 ± 7.6 years, range 6–39 years). Lungs and perfusion defects were segmented automatically to quantify perfusion defects in percent (QDP). Pulmonary blood flow (PBF), mean transit time (MTT), and perfusion delay were calculated for the whole lung, inside normally perfused and perfusion defect areas. Chest MRI score and BAD were assessed visually.</p> Results <p>QDP and PBF correlated with MRI global score (<i>r</i> = 0.58 and −0.53, <i>p</i> &lt; 0.001). In normally perfused lung, PBF was higher (161.2 ± 77.9 mL/100 mL/min vs. 57.5 ± 26.4 mL/100 mL/min, <i>p</i> &lt; 0.001), and MTT (5.4 ± 1.7 s vs. 6.9 ± 2.3 s, <i>p</i> &lt; 0.001) and perfusion delay were shorter than in perfusion defect areas (4.6 ± 5.3 s vs.&#xa0;13.4 ± 16.2 s, <i>p</i> &lt; 0.001). 48 (64.0%) patients showed BAD, had higher QDP (44.6 ± 20.8% vs. 17.3 ± 11.0%, <i>p</i> &lt; 0.001) and lower PBF (91.9 ± 54.8 mL/100 mL/min vs. 178.3 ± 77.4 mL/100 mL/min, <i>p</i> &lt; 0.001) than patients without BAD. MTT was shorter (6.3 ± 1.9 s vs. 8.0 ± 2.6 s, <i>p</i> &lt; 0.001), and perfusion delay was longer (13.8 ± 10.1 s vs. 12.8 ± 23.7 s, <i>p</i> &lt; 0.02) inside perfusion defects of patients with BAD compared to without BAD.</p> Conclusion <p>Perfusion parameters correlate with lung disease severity, and perfusion defects showed delayed perfusion in patients with CF. BAD was associated with more extensive perfusion defects and reduced PBF.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>Dilated bronchial arteries are a common comorbidity in cystic fibrosis (CF), which can cause hemoptysis, but their quantitative contribution to lung perfusion is little researched</i>.</p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>Perfusion defects in percent (QDP) enabled objective assessment of perfusion abnormalities in CF patients, while perfusion delay and arterial correlation showed bronchial artery perfusion contribution</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>The usage of quantitative perfusion metrics in CF may help tracking disease progression. By also including the proposed metrics perfusion delay and arterial correlation, bronchial artery inflow could be assessed and used to detect early onset of bronchial artery dilation</i>.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Quantitative MRI detects delayed perfusion and impact of bronchial artery dilatation on pulmonary circulation in patients with cystic fibrosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月16日

查看全文
  • Patricia Leutz-Schmidt,
  • Julian Grolig,
  • Lena Wucherpfennig,
  • Olaf Sommerburg,
  • Monika Eichinger,
  • Sabine Wege,
  • Simon Y. Graeber,
  • Jens-Peter Schenk,
  • Abdulsattar Alrajab,
  • Hans-Ulrich Kauczor,
  • Mirjam Stahl,
  • Marcus A. Mall,
  • Arnd Koeppe,
  • Britta Nestler,
  • Michael Selzer,
  • Simon M. F. Triphan,
  • Mark O. Wielpütz

摘要

Objectives

MRI detects abnormal lung perfusion in patients with cystic fibrosis (CF). However, little is known about the contribution of bronchial arteries to lung perfusion in CF. We hypothesized that delayed perfusion can be detected by dynamic contrast-enhanced (DCE-)MRI and that bronchial artery dilatation (BAD) is associated with changes in lung perfusion.

Materials and methods

Morpho-functional MRI was prospectively acquired in 75 patients with CF (18.7 ± 7.6 years, range 6–39 years). Lungs and perfusion defects were segmented automatically to quantify perfusion defects in percent (QDP). Pulmonary blood flow (PBF), mean transit time (MTT), and perfusion delay were calculated for the whole lung, inside normally perfused and perfusion defect areas. Chest MRI score and BAD were assessed visually.

Results

QDP and PBF correlated with MRI global score (r = 0.58 and −0.53, p < 0.001). In normally perfused lung, PBF was higher (161.2 ± 77.9 mL/100 mL/min vs. 57.5 ± 26.4 mL/100 mL/min, p < 0.001), and MTT (5.4 ± 1.7 s vs. 6.9 ± 2.3 s, p < 0.001) and perfusion delay were shorter than in perfusion defect areas (4.6 ± 5.3 s vs. 13.4 ± 16.2 s, p < 0.001). 48 (64.0%) patients showed BAD, had higher QDP (44.6 ± 20.8% vs. 17.3 ± 11.0%, p < 0.001) and lower PBF (91.9 ± 54.8 mL/100 mL/min vs. 178.3 ± 77.4 mL/100 mL/min, p < 0.001) than patients without BAD. MTT was shorter (6.3 ± 1.9 s vs. 8.0 ± 2.6 s, p < 0.001), and perfusion delay was longer (13.8 ± 10.1 s vs. 12.8 ± 23.7 s, p < 0.02) inside perfusion defects of patients with BAD compared to without BAD.

Conclusion

Perfusion parameters correlate with lung disease severity, and perfusion defects showed delayed perfusion in patients with CF. BAD was associated with more extensive perfusion defects and reduced PBF.

Key Points

Question Dilated bronchial arteries are a common comorbidity in cystic fibrosis (CF), which can cause hemoptysis, but their quantitative contribution to lung perfusion is little researched.

Findings Perfusion defects in percent (QDP) enabled objective assessment of perfusion abnormalities in CF patients, while perfusion delay and arterial correlation showed bronchial artery perfusion contribution.

Clinical relevance The usage of quantitative perfusion metrics in CF may help tracking disease progression. By also including the proposed metrics perfusion delay and arterial correlation, bronchial artery inflow could be assessed and used to detect early onset of bronchial artery dilation.

Graphical Abstract